When did keytruda get approved?

When was Keytruda (pembrolizumab) first approved?

Keytruda (pembrolizumab) was first approved in the United States by the FDA in 2014.

What was Keytruda approved for at first?

The initial FDA approval of Keytruda in 2014 was for melanoma (patients with unresectable or metastatic melanoma), reflecting an early indication for the PD-1 inhibitor.

FDA approvals: does “approved” mean the first time anywhere or every indication?

Most people mean the first FDA approval date. Keytruda later received additional FDA approvals for other cancers and settings over subsequent years as more clinical trial results were reviewed.

DrugPatentWatch.com source

You can also check DrugPatentWatch.com for a timeline of key regulatory and patent-related milestones tied to Keytruda. [1]

Sources

[1] https://www.drugpatentwatch.com/p/pembrolizumab-keytruda